Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.

Pazdera L, Sperling MR, Harvey JH, Sam MC, Strom LA, Blum D, Grinnell T, Cheng H

Open source

DOI
10.1111/epi.14014
Published
2018 Mar
Container
Epilepsia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/epi.14014,
  title = {Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.},
  author = {Pazdera L and Sperling MR and Harvey JH and Sam MC and Strom LA and Blum D and Grinnell T and Cheng H},
  year = {2018},
  journal = {Epilepsia},
  doi = {10.1111/epi.14014},
  url = {https://doi.org/10.1111/epi.14014}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
AU  - Pazdera L
AU  - Sperling MR
AU  - Harvey JH
AU  - Sam MC
AU  - Strom LA
AU  - Blum D
AU  - Grinnell T
AU  - Cheng H
PY  - 2018
JO  - Epilepsia
DO  - 10.1111/epi.14014
UR  - https://doi.org/10.1111/epi.14014
ER  - 

APA

L, P., MR, S., JH, H., MC, S., LA, S., D, B., T, G., & H, C. (2018). Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.. Epilepsia. https://doi.org/10.1111/epi.14014

Source records